Quarterly report pursuant to Section 13 or 15(d)
Cover
Document and Entity Information
Financial Statements
Condensed Consolidated Balance Sheets (Unaudited)
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)
Condensed Consolidated Statements of Operations (Unaudited)
Condensed Consolidated Statements of Stockholders' Equity (Unaudited)
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical)
Condensed Consolidated Statements of Cash Flows (Unaudited)
Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)
Notes to Financial Statements
Interim Financial Statements
Intangible Assets
Stock Based Compensation
Litigation
Abeona Therapeutics LLC Acquisition
Notes Tables
Intangible Assets (Tables)
Stock Based Compensation (Tables)
Abeona Therapeutics LLC Acquisition (Tables)
Notes Details
Intangible Assets (Details)
Stock Based Compensation (Details)
Litigation (Details)
Abeona Therapeutics LLC Acquisition (Details)
Litigation (Details)
v3.3.0.814
Litigation (Details)
9 Months Ended
Sep. 30, 2015
Defendant
Litigation [Abstract]
Number of defendants
30
X
- References
No definition available.
+ Details
Name:
us-gaap_LossContingencyInformationAboutLitigationMattersAbstract
Namespace Prefix:
us-gaap_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Number of defendants named in a legal action.
+ References
No definition available.
+ Details
Name:
us-gaap_LossContingencyNumberOfDefendants
Namespace Prefix:
us-gaap_
Data Type:
xbrli:integerItemType
Balance Type:
na
Period Type:
duration